Mycophenolic Acid (Accord Healthcare Inc.)


Welcome to the PulseAid listing for the Mycophenolic Acid drug offered from Accord Healthcare Inc.. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Accord Healthcare Inc.
NON-PROPRIETARY NAME: Mycophenolic Acid
SUBSTANCE NAME: MYCOPHENOLATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antimetabolite Immunosuppressant [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, DELAYED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-09-11
END MARKETING DATE: 0000-00-00


Mycophenolic Acid HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMycophenolic Acid from Accord Healthcare Inc.
LABELER NAME: Accord Healthcare Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 360(mg/1)
START MARKETING DATE: 2017-09-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 16729-189_5902a650-722c-3c98-e053-2a91aa0a9549
PRODUCT NDC: 16729-189
APPLICATION NUMBER: ANDA202555

Other MYCOPHENOLATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Mycophenolic Acid
American Health PackagingMycophenolic Acid
Apotex CorpMycophenolic Acid
Avera McKennan HospitalMyfortic
Golden State Medical Supply, Inc.Mycophenolic Acid
Novartis Pharmaceuticals CorporationMyfortic